MedPath

To assess pain and discomfort and use measures to decrease pain during surfactant administration in premature babies

Not Applicable
Conditions
Health Condition 1: P220- Respiratory distress syndrome of newborn
Registration Number
CTRI/2024/05/066746
Lead Sponsor
Department of Neonatology Government medical College Chh Sambhajinagar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

All babies of GA less than 37 weeks with diagnosis of RDS requiring surfactant therapy with either LISA or INSURE methods.

Exclusion Criteria

1.Intubation before the study entry

2.Perinatal asphyxia

3.IVH more than grade II

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To assess Pain profile during surfactant therapy with either LISA or INSURE method in preterm neonates diagnosed with RDSTimepoint: 1 Before surfactant administration <br/ ><br>2 During laryngoscopy <br/ ><br>3 During surfactant administration <br/ ><br>4 After the procedure
Secondary Outcome Measures
NameTimeMethod
Adequacy of analgesiaTimepoint: During surfactant therapy
© Copyright 2025. All Rights Reserved by MedPath